•  
  •  
  •  
  •  

2026-05-29 04:13:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores

Keywords Selected:  USA

Research

  • 45% of Newbie traders claim that 'not knowing enough' is the primary reason for losses incurred in Futures & Options trading - Sharekhan's survey reveals
  • Domestic primary aluminium manufacturing entities are behind the curve in the transition to a greener future: ICRA
  • Campus Activewear - IPO - Strong Business Model, but Valuation is Stretched

Stock Report

  • Campus Activewear Limited announces Q4 & FY26 performance
  • Sunita Defense Inc, USA has established its full time office in Chicago USA
  • Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
  • Carysil Limited Announces 25% Expansion in Quartz Sink Capacity for US Retail Giants
  • Lupin Pharmaceuticals, Inc, USA enters into settlement agreement with Humana Inc
  • Unichem Pharmaceuticals (USA) Issues Voluntary Recall of Buspirone Hydrochloride Tablets
  • 3i Infotech Inc., USA receives order worth Rs. 2.76 crores
  • 3i Infotech Inc., USA receives order worth approx. Rs. 1.63 crores
  • Glenmark Pharmaceuticals announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S.
  • Glenmark Therapeutics Inc., USA launches Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)
  • Sunita Tools Ltd forms Wholly Owned Subsidiary, Sunita Defence Inc, in Wyoming, USA
  • 3i Infotech Inc., USA receives order worth Rs. 2.21 crores
  • TCS launches Gemini Experience Center in the US to help accelerate AI-powered manufacturing
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • LT Foods Secures Major Relief in U.S. Countervailing Duty Review
  • Biocon obtains approval for weight management drug, Liraglutide, in the United States
  • Lupin announces the approval and launch of Brivaracetam Oral Solution in the United States
  • TCS and Rajarambapu Sahakari Bank Deepen Partnership, Integrate TCS BaNCS for Treasury to Enhance Operations
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • AION-Tech Solutions and Bulgarian Company Theoremus AD Sign MoU to Advance Multimodal Urban Mobility in India
  • Aion-Tech Solutions Ltd enters into MoU with Theoremus AD
  • Powerhouse Engines Selects Ramco Systems to Transform Engine MRO Operations
  • Sathgen Therapeutics Division expands to the U.S. with Launch of Princeton Based Subsidiary
  • Fineotex Chemical Ltd announces Strategic Acquisition of a Leading U.S. Specialty Oilfield Chemicals Group

Industry News

  • LiaPlus AI raises INR 2 Crore in Seed Round led by Inflection Point Ventures

Latest Post

  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025